Sarah Gheuens - Sep 1, 2021 Form 3 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Medical Officer
Signature
/s/ William Cook, as attorney-in-fact for Sarah Gheuens
Stock symbol
AGIO
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
3
Date filed
9/10/2021, 09:32 PM
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGIO Common stock 3.46K Sep 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AGIO Stock option (right to buy) Sep 1, 2021 Common stock 6.04K $38.72 Direct F1
holding AGIO Restricted stock units Sep 1, 2021 Common stock 1.67K Direct F2, F3
holding AGIO Restricted stock units Sep 1, 2021 Common stock 6.49K Direct F3, F4
holding AGIO Restricted stock units Sep 1, 2021 Common stock 9.38K Direct F3, F5
holding AGIO Stock option (right to buy) Sep 1, 2021 Common stock 3.24K $56.68 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 2, 2019. The shares underlying this option vest as to 25% of the underlying shares on December 2, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F2 The restricted stock units were granted on December 2, 2019. Beginning on December 2, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4 The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
F5 The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.
F6 This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.